QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Indaptus Therapeutics (INDP) Insider Trading & Ownership

$2.79
+0.17 (+6.49%)
(As of 03:19 PM ET)

Indaptus Therapeutics (NASDAQ:INDP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$142,052.32
Number Of
Insiders Selling
(Last 12 Months)
0
Get INDP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INDP Insider Buying and Selling by Quarter

Indaptus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2023Glen R AndersonMajor ShareholderBuy23,934$2.34$56,005.56  
8/10/2023Glen R AndersonMajor ShareholderBuy44,354$1.94$86,046.76  
(Data available from 1/1/2013 forward)

INDP Insider Trading Activity - Frequently Asked Questions

Who is on Indaptus Therapeutics's Insider Roster?

The list of insiders at Indaptus Therapeutics includes Boyan Vesselinov Litchev, Glen R Anderson, Jeffrey A Meckler, Michael James Newman, and Walt Addison Linscott. Learn more on insiders at INDP.

What percentage of Indaptus Therapeutics stock is owned by insiders?

27.10% of Indaptus Therapeutics stock is owned by insiders. Learn more on INDP's insider holdings.

Which Indaptus Therapeutics insiders have been buying company stock?

The following insiders have purchased INDP shares in the last 24 months: Boyan Vesselinov Litchev ($1,850.00), Glen R Anderson ($142,052.32), Jeffrey A Meckler ($99,688.41), and Walt Addison Linscott ($393.00).

How much insider buying is happening at Indaptus Therapeutics?

Insiders have purchased a total of 109,473 INDP shares in the last 24 months for a total of $243,983.73 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:INDP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners